Role and Function of O-GlcNAcylation in Cancer

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2021 Nov 13

PMID 34771527

Citations 37

Authors

Jii Bum Lee

Kyoung-Ho Pyo

Hye Ryun Kim

Affiliations

Soon will be listed here.

Abstract

Cancer cells are able to reprogram their glucose metabolism and retain energy via glycolysis even under aerobic conditions. They activate the hexosamine biosynthetic pathway (HBP), and the complex interplay of O-linked N-acetylglucosaminylation (O-GlcNAcylation) via deprivation of nutrients or increase in cellular stress results in the proliferation, progression, and metastasis of cancer cells. Notably, cancer is one of the emerging diseases associated with O-GlcNAcylation. In this review, we summarize studies that delineate the role of O-GlcNAcylation in cancer, including its modulation in metastasis, function with receptor tyrosine kinases, and resistance to chemotherapeutic agents, such as cisplatin. In addition, we discuss the function of O-GlcNAcylation in eliciting immune responses associated with immune surveillance in the tumor microenvironment. O-GlcNAcylation is increasingly accepted as one of the key players involved in the activation and differentiation of T cells and macrophages. Finally, we discuss the prognostic role of O-GlcNAcylation and potential therapeutic agents such as O-linked β-N-acetylglucosamine-transferase inhibitors, which may help overcome the resistance mechanism associated with the reprogramming of glucose metabolism.

Citing Articles

Crosstalk between O-GlcNAcylation and phosphorylation in metabolism: regulation and mechanism.

Zhao Q, Zhou S, Lou W, Qian H, Xu Z Cell Death Differ. 2025; .

PMID: 40045035 DOI: 10.1038/s41418-025-01473-z.

DC. Regulates Vascular Smooth Muscle Cell Proliferation by Modulating -GlcNAc and MOF Expression.

Na H, Kim J, Kim Y, Lee S, Sung M Prev Nutr Food Sci. 2025; 29(4):430-440.

PMID: 39759825 PMC: 11699568. DOI: 10.3746/pnf.2024.29.4.430.

OGT promotes the ferroptosis of chondrocytes in osteoarthritis development via O-GlcNAcylation modification of ACSF2.

Zhang Y, Qiao Z, He M, Xia J Immunol Res. 2024; 73(1):7.

PMID: 39666251 DOI: 10.1007/s12026-024-09567-5.

Astragalus polysaccharide treatment relieves cerebral ischemia‒reperfusion injury by promoting M2 polarization of microglia by enhancing O-GlcNAcylation.

Wang M, Zhu W, Guo Y, Zeng H, Liu J, Liu J Metab Brain Dis. 2024; 40(1):16.

PMID: 39560836 DOI: 10.1007/s11011-024-01420-w.

Glut3 promotes cellular O-GlcNAcylation as a distinctive tumor-supportive feature in Treg cells.

Sharma A, Sharma G, Gao Z, Li K, Li M, Wu M Cell Mol Immunol. 2024; 21(12):1474-1490.

PMID: 39468304 PMC: 11606946. DOI: 10.1038/s41423-024-01229-8.

References

Yan M, Xu Q, Zhang P, Zhou X, Zhang Z, Chen W . Correlation of NF-kappaB signal pathway with tumor metastasis of human head and neck squamous cell carcinoma. BMC Cancer. 2010; 10:437. PMC: 2931490. DOI: 10.1186/1471-2407-10-437. View

Li X, Gong W, Wang H, Li T, Attri K, Lewis R . O-GlcNAc Transferase Suppresses Inflammation and Necroptosis by Targeting Receptor-Interacting Serine/Threonine-Protein Kinase 3. Immunity. 2019; 50(3):576-590.e6. PMC: 6426684. DOI: 10.1016/j.immuni.2019.01.007. View

Ruan H, Nie Y, Yang X . Regulation of protein degradation by O-GlcNAcylation: crosstalk with ubiquitination. Mol Cell Proteomics. 2013; 12(12):3489-97. PMC: 3861702. DOI: 10.1074/mcp.R113.029751. View

Akella N, Le Minh G, Ciraku L, Mukherjee A, Bacigalupa Z, Mukhopadhyay D . O-GlcNAc Transferase Regulates Cancer Stem-like Potential of Breast Cancer Cells. Mol Cancer Res. 2020; 18(4):585-598. PMC: 7127962. DOI: 10.1158/1541-7786.MCR-19-0732. View

Ruan H, Singh J, Li M, Wu J, Yang X . Cracking the O-GlcNAc code in metabolism. Trends Endocrinol Metab. 2013; 24(6):301-9. PMC: 3783028. DOI: 10.1016/j.tem.2013.02.002. View

Ali A, Kim S, Kim M, Choi M, Kang S, Cho G . O-GlcNAcylation of NF-κB Promotes Lung Metastasis of Cervical Cancer Cells via Upregulation of CXCR4 Expression. Mol Cells. 2017; 40(7):476-484. PMC: 5547217. DOI: 10.14348/molcells.2017.2309. View

Liu B, Salgado O, Singh S, Hippen K, Maynard J, Burlingame A . The lineage stability and suppressive program of regulatory T cells require protein O-GlcNAcylation. Nat Commun. 2019; 10(1):354. PMC: 6341091. DOI: 10.1038/s41467-019-08300-3. View

Itkonen H, Poulose N, Steele R, Martin S, Levine Z, Duveau D . Inhibition of O-GlcNAc Transferase Renders Prostate Cancer Cells Dependent on CDK9. Mol Cancer Res. 2020; 18(10):1512-1521. PMC: 7541471. DOI: 10.1158/1541-7786.MCR-20-0339. View

Prenen H, Mazzone M . Tumor-associated macrophages: a short compendium. Cell Mol Life Sci. 2019; 76(8):1447-1458. PMC: 11105658. DOI: 10.1007/s00018-018-2997-3. View

10.

Zhang K, Yin R, Yang X . O-GlcNAc: A Bittersweet Switch in Liver. Front Endocrinol (Lausanne). 2015; 5:221. PMC: 4269194. DOI: 10.3389/fendo.2014.00221. View

11.

Stateva S, Villalobo A . O-GlcNAcylation of the human epidermal growth factor receptor. Org Biomol Chem. 2015; 13(30):8196-204. DOI: 10.1039/c5ob00443h. View

12.

Elsen N, Patel S, Ford R, Hall D, Hess F, Kandula H . Insights into activity and inhibition from the crystal structure of human O-GlcNAcase. Nat Chem Biol. 2017; 13(6):613-615. DOI: 10.1038/nchembio.2357. View

13.

Hu C, Tien S, Hsieh P, Jeng Y, Chang M, Chang Y . High Glucose Triggers Nucleotide Imbalance through O-GlcNAcylation of Key Enzymes and Induces KRAS Mutation in Pancreatic Cells. Cell Metab. 2019; 29(6):1334-1349.e10. DOI: 10.1016/j.cmet.2019.02.005. View

14.

Rossi A, Di Maio M, Chiodini P, Rudd R, Okamoto H, Skarlos D . Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data. J Clin Oncol. 2012; 30(14):1692-8. DOI: 10.1200/JCO.2011.40.4905. View

15.

Love D, Kochan J, Cathey R, Shin S, Hanover J, Kochran J . Mitochondrial and nucleocytoplasmic targeting of O-linked GlcNAc transferase. J Cell Sci. 2003; 116(Pt 4):647-54. DOI: 10.1242/jcs.00246. View

16.

Chanmee T, Ontong P, Konno K, Itano N . Tumor-associated macrophages as major players in the tumor microenvironment. Cancers (Basel). 2014; 6(3):1670-90. PMC: 4190561. DOI: 10.3390/cancers6031670. View

17.

Lin Y, Lin C, Yeh Y, Ho H, Wu Y, Chen M . High -linked -acetylglucosamine transferase expression predicts poor survival in patients with early stage lung adenocarcinoma. Oncotarget. 2018; 9(57):31032-31044. PMC: 6089550. DOI: 10.18632/oncotarget.25772. View

18.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

19.

Dehennaut V, Leprince D, Lefebvre T . O-GlcNAcylation, an Epigenetic Mark. Focus on the Histone Code, TET Family Proteins, and Polycomb Group Proteins. Front Endocrinol (Lausanne). 2014; 5:155. PMC: 4176146. DOI: 10.3389/fendo.2014.00155. View

20.

Ruland J . Colon Cancer: Epithelial Notch Signaling Recruits Neutrophils to Drive Metastasis. Cancer Cell. 2019; 36(3):213-214. DOI: 10.1016/j.ccell.2019.08.010. View